Edge Therapeutics' IPO

Edge Therapeutics raised a round of funding on October 01, 2015. Investors include Public.

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the manag…

Articles about Edge Therapeutics' IPO: